RAD21 and adrenal cortex carcinoma: The association of high RAD21 expression with lower survival was also observed in multiple cancer types, including adrenocortical carcinoma, bladder urothelial carcinoma, cervical squamous cell carcinoma, lung squamous cell carcinoma, mesothelioma, and sarcoma (Supplemental Figure 1, G–L).